IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms.
Mager LF, Riether C, Schürch CM, Banz Y, Wasmer MH, Stuber R, Theocharides AP, Li X, Xia Y, Saito H, Nakae S, Baerlocher GM, Manz MG, McCoy KD, Macpherson AJ, Ochsenbein AF, Beutler B, Krebs P.
Mager LF, et al. Among authors: krebs p.
J Clin Invest. 2015 Jul 1;125(7):2579-91. doi: 10.1172/JCI77347. Epub 2015 May 26.
J Clin Invest. 2015.
PMID: 26011644
Free PMC article.